Evidence map›Paper›PMID 34010494›Full record

Trial reportDepression and anxiety2021

Sleep quality and outcome of exposure therapy in adults with social anxiety disorder.

Christina D Dutcher, Sheila M Dowd, Alyson K Zalta, Daniel J Taylor, David Rosenfield, Alexander Perrone, Michael W Otto, Mark H Pollack, Stefan G Hofmann, Jasper A J Smits

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Depression and anxiety, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Impact of Sleep on Fear Extinction.Current topics in behavioral neurosciences · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Christina D DutcherDepartment of Psychology, Institute for Mental Health Research, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-3158-8674
Sheila M DowdDepartment of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Alyson K ZaltaDepartment of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA.ORCID 0000-0002-5159-8431
Daniel J TaylorDepartment of Psychology, University of Arizona, Tucson, Arizona, USA.
David RosenfieldDepartment of Psychology, Southern Methodist University, Dallas, Texas, USA.ORCID 0000-0002-3743-9186
Alexander PerroneDepartment of Psychology, Institute for Mental Health Research, The University of Texas at Austin, Austin, Texas, USA.
Michael W OttoDepartment of Psychological and Brain Sciences, Boston University, Boston, Massachusetts, USA.
Mark H PollackDepartment of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Stefan G HofmannDepartment of Psychological and Brain Sciences, Boston University, Boston, Massachusetts, USA.
Jasper A J SmitsDepartment of Psychology, Institute for Mental Health Research, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0003-1633-9693
Rush University Medical Center · USTexas Research Institute · USBoston University · USSouthern Methodist University · USUniversity of Arizona · US

Funding

Connectomes Related to Anxiety and Depression in AdolescentsU01MH108168 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIELI, JOHN, WHITFIELD-GABRIELI, SUSAN · 2015 to 2019
$4.6M
Toward Outcome Measurement of Anxiety in Youth with Autism Spectrum DisordersR01MH099021 · NIMH · YALE UNIVERSITY · PI SCAHILL, LAWRENCE D. · 2012 to 2015
$2.7M
1/2-Yoga For Generalized Anxiety DisorderR01AT007257 · NCCIH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2013 to 2017
$2.0M
Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma PsychopathologyK23MH103394 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI ZALTA, ALYSON KAY · 2014 to 2018
$769k
2/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety DisorderR34MH099311 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2014 to 2016
$737k
Dose Timing of D-cycloserine to Augment CBT for Social Anxiety DisorderR34MH099309 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI POLLACK, MARK H · 2014 to 2016
$698k
3/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety DisorderR34MH099318 · NIMH · UNIVERSITY OF TEXAS AT AUSTIN · PI SMITS, JASPER · 2014 to 2016
$695k
NCCIH NIH HHS R01 AT007257NIMH NIH HHS K23 MH103394NIMH NIH HHS R01 MH099021NIMH NIH HHS R34 MH099309NIMH NIH HHS R34 MH099311NIMH NIH HHS R34 MH099318NIMH NIH HHS U01 MH108168
6 · The paper itself

Abstract

introductionPoor sleep is prevalent among individuals with social anxiety disorder (SAD) and may negatively affect exposure therapy outcomes. Poor sleep may impair memory and learning, and thus compromise fear extinction learning thought to take place in exposure therapy. We examined poor sleep as a predictor of exposure therapy outcomes for SAD and the moderating role of d-cycloserine (DCS) on this relationship.

methodsParticipants were 152 individuals with a primary diagnosis of SAD. As part of a randomized clinical trial evaluating the efficacy of DCS for enhancing the effects of exposure therapy, they completed self-report baseline measure of sleep quality, and self-report sleep diaries assessing sleep duration (total sleep time [TST]) and sleep quality the nights before and after treatment sessions.

resultsPoorer baseline sleep quality was significantly associated with slower improvement over time and worse symptom outcomes at the end of treatment and follow-up after controlling for baseline symptoms of depression and social anxiety. Greater TST the night before treatment predicted lower SAD symptoms at the next session, after controlling for symptoms at the previous session. There was no relation between prior or subsequent night sleep quality on symptoms at the next session. No associations were moderated by DCS.

conclusionsWe replicated and extended findings indicating that poor sleep quality is associated with poorer exposure therapy outcomes for SAD. Assessing for sleep difficulties before treatment initiation and incorporating sleep interventions into treatment may enhance exposure therapy outcomes for SAD.

Indexed as

Implosive TherapyPhobia, SocialAdultExtinction, PsychologicalFearHumansSleep QualityTreatment Outcomecognitive behavioral therapyd-cycloserineexposure therapysleep difficultiessleep qualitysocial anxiety disordertreatment outcomes

Identifiers

PMID34010494
PMCPMC8560555
OpenAlexW3161572623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.